Cita APA

Li, X., Yu, X., Zhou, D., Chen, B., Li, W., Zheng, X., . . . Zhou, W. (2020). CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis. Front Pharmacol.

Citación estilo Chicago

Li, Xiaoli, Xiaoping Yu, Duanfang Zhou, Bo Chen, Wenjun Li, Xiangru Zheng, Hongfang Zeng, Liangyuan Long, y Weiying Zhou. "CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis." Front Pharmacol 2020.

Cita MLA

Li, Xiaoli, et al. "CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis." Front Pharmacol 2020.